The mission of our consulting group is to provide strategic guidance to scientists who wish to commercialize their biomedical inventions, like new medical devices, diagnostics and new therapeutics. We rely on motivated Kellogg MBA students interested in the biotech entrepreneurship, consulting and venture capital to assess the commercial potential of Northwestern innovations. We form interdisciplinary teams of 3-5 graduate students to work on the project for 10 weeks. We work closely with our clients (scientists) to deliver actionable recommendations regarding the commercialization options for particular technologies. Our objective is to provide training to MBA students and consulting services to scientists. This creates potential partnerships for new biotech business ventures. I2C is a collaborative effort among the Kellogg School of Management, the NUCATS Institute and Innovations and New Ventures Office (INVO) at Northwestern University. Prof. Alicia Loffler is our faculty advisor.